Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
23.78
-0.04 (-0.17%)
Apr 30, 2025, 3:04 PM CST
SHE:002287 Revenue
Tibet Cheezheng Tibetan Medicine had revenue of 403.02M CNY in the quarter ending March 31, 2025, with 10.39% growth. This brings the company's revenue in the last twelve months to 2.38B, up 12.37% year-over-year. In the year 2024, Tibet Cheezheng Tibetan Medicine had annual revenue of 2.34B with 14.32% growth.
Revenue (ttm)
2.38B
Revenue Growth
+12.37%
P/S Ratio
5.31
Revenue / Employee
768.61K
Employees
3,091
Market Cap
12.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.34B | 292.82M | 14.32% |
Dec 31, 2023 | 2.05B | 363.07K | 0.02% |
Jan 1, 2023 | 2.04B | 274.30M | 15.49% |
Jan 1, 2022 | 1.77B | 285.43M | 19.22% |
Dec 31, 2020 | 1.49B | 82.38M | 5.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Jan 1, 2019 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |